BNP Paribas in Switzerland Supports Record CHF Bond Deal for Thermo Fisher Scientific
BNP Paribas in Switzerland is proud to have acted as Active Bookrunner on Thermo Fisher Scientific’s landmark CHF 1.425 billion bond issuance, executed across multiple tranches:
- 1.5 year: CHF 410 million
- 4 year: CHF 315 million
- 8 year: CHF 350 million
- 12 year: CHF 215 million
- 20 year: CHF 135 million
This transaction represents the largest CHF-denominated bond offering ever completed by a US corporate, reinforcing the strength of both Thermo Fisher Scientic’s credit profile and the enduring appetite of Swiss investors.
This deal marks the fourth time BNP Paribas has supported Thermo Fisher in an Active Bookrunner role and the second consecutive CHF mandate for the company—further evidence of a trusted and growing partnership.
The successful outcome of this issuance demonstrates BNP Paribas’ ongoing commitment to supporting its clients with innovative and impactful capital markets solutions. It also highlights our deep expertise in the Swiss franc bond market and our ability to connect global issuers with robust investor demand.
We are grateful to Thermo Fisher Scientific for their continued trust and extend our thanks to all teams involved for their dedication.
This transaction represents the largest CHF-denominated bond offering ever completed by a US corporate.
